Is Skyward Specialty Insurance Group (SKWD) Expensive As It Expands Into U.S. AV Insurance?

Skyward Specialty Insurance Group (SKWD) just pushed deeper into autonomous vehicles by extending ibott’s AV expertise into the U.S. primary insurance market, providing a full suite of coverage options for customers across the ecosystem.

The ibott expansion into U.S. autonomous vehicles comes at a time when Skyward Specialty Insurance Group’s short term momentum is already strong, with a 7 day share price return of 8.5% and a year to date share price gain of 23.16%. The 3 year total shareholder return of 108.42% points to steady longer term compounding.

Scan beyond Skyward Specialty Insurance Group and explore other insurers in specialty niches through our hand picked list of solid balance sheet and fundamentals (25 results)

After a sharp run on the ibott news, the choice now is simple: pay up for Skyward Specialty Insurance Group’s momentum, or wait and see what the valuation actually offers at today’s price.

Most Popular Narrative: 15.1% Undervalued

On the widely followed narrative view, Skyward Specialty Insurance Group screens as undervalued, with a fair value of $70.55 against a last close of $59.88. This puts the ibott momentum into a broader story about specialty lines, fee income and underwriting discipline.

The build out of diversified specialty lines such as Accident & Health, agriculture, credit and surety, and specialty programs is creating multiple premium streams that management describes as largely insulated from traditional property and casualty cycles. According to this view, these features can support steadier revenue and earnings quality for Skyward Specialty Insurance Group.

See why 14 investors see Skyward Specialty Insurance Group as 15% undervalued.

Result: Fair Value of $70.55 (UNDERVALUED)

Still, the narrative around Skyward Specialty Insurance Group can be knocked off course if catastrophe losses spike again or higher Accident & Health claims erode underwriting margins.

Find out about the key risks to this Skyward Specialty Insurance Group narrative.

Another View: Skyward Specialty Insurance Group On Earnings Multiples

There is a catch. On a simple P/E check, Skyward Specialty Insurance Group looks expensive, trading at 14.1x earnings versus 10.8x for the wider US Insurance group and 9.1x for closer peers. The fair ratio sits at 12.4x, which points to less margin for error if sentiment cools.

For investors weighing this against the earlier fair value story, it helps to see what the numbers imply in detail, including where the market could gravitate if conditions change, through the See what the numbers say about this price — find out in our valuation breakdown..

Next Steps

Sentiment around Skyward Specialty Insurance Group is split, which is exactly why you should review the numbers yourself and move quickly while interest is high. To understand what investors see in the upside case, review the 3 key rewards.

Looking for more investment ideas beyond Skyward Specialty Insurance Group?

If you only stop at Skyward Specialty Insurance Group, you could miss other high quality setups that fit your goals just as well or even better.

• Target potential mispricings by running through the 29 high quality undervalued stocks that line up strong fundamentals with prices that may not yet fully reflect them.
• Build income resilience by scanning the 8 dividend fortresses that combine higher yields with businesses focused on keeping payouts covered.
• Protect your downside first by filtering for 31 resilient stocks with low risk scores that pair sturdier balance sheets with more controlled risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com